179 related articles for article (PubMed ID: 19561398)
1. Comparative study of synonymous codon usage variations between the nucleocapsid and spike genes of coronavirus, and C-type lectin domain genes of human and mouse.
Ahn I; Jeong BJ; Son HS
Exp Mol Med; 2009 Oct; 41(10):746-56. PubMed ID: 19561398
[TBL] [Abstract][Full Text] [Related]
2. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
3. Analysis of synonymous codon usage in SARS Coronavirus and other viruses in the Nidovirales.
Gu W; Zhou T; Ma J; Sun X; Lu Z
Virus Res; 2004 May; 101(2):155-61. PubMed ID: 15041183
[TBL] [Abstract][Full Text] [Related]
4. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.
Liu L; Fang Q; Deng F; Wang H; Yi CE; Ba L; Yu W; Lin RD; Li T; Hu Z; Ho DD; Zhang L; Chen Z
J Virol; 2007 May; 81(9):4694-700. PubMed ID: 17314167
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses.
Gu H; Chu DKW; Peiris M; Poon LLM
Virus Evol; 2020 Jan; 6(1):veaa032. PubMed ID: 32431949
[TBL] [Abstract][Full Text] [Related]
6. SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting.
Rest JS; Mindell DP
Infect Genet Evol; 2003 Sep; 3(3):219-25. PubMed ID: 14522185
[TBL] [Abstract][Full Text] [Related]
7. Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups.
Zhang CY; Wei JF; He SH
BMC Microbiol; 2006 Oct; 6():88. PubMed ID: 17020602
[TBL] [Abstract][Full Text] [Related]
8. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
9. Comparative genetic analyses of Korean bat coronaviruses with SARS-CoV and the newly emerged SARS-CoV-2.
Na EJ; Lee SY; Kim HJ; Oem JK
J Vet Sci; 2021 Jan; 22(1):e12. PubMed ID: 33522164
[TBL] [Abstract][Full Text] [Related]
10. Mosaic evolution of the severe acute respiratory syndrome coronavirus.
Stavrinides J; Guttman DS
J Virol; 2004 Jan; 78(1):76-82. PubMed ID: 14671089
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
Nambou K; Anakpa M
Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
[TBL] [Abstract][Full Text] [Related]
12. Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.
Sheikh A; Al-Taher A; Al-Nazawi M; Al-Mubarak AI; Kandeel M
J Virol Methods; 2020 Mar; 277():113806. PubMed ID: 31911390
[TBL] [Abstract][Full Text] [Related]
13. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
[TBL] [Abstract][Full Text] [Related]
14. Relative synonymous codon usage of ORF1ab in SARS-CoV-2 and SARS-CoV.
Li G; Zhang L; Du N
Genes Genomics; 2021 Nov; 43(11):1351-1359. PubMed ID: 34228320
[TBL] [Abstract][Full Text] [Related]
15. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.
Sui J; Li W; Roberts A; Matthews LJ; Murakami A; Vogel L; Wong SK; Subbarao K; Farzan M; Marasco WA
J Virol; 2005 May; 79(10):5900-6. PubMed ID: 15857975
[TBL] [Abstract][Full Text] [Related]
17. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.
Song HD; Tu CC; Zhang GW; Wang SY; Zheng K; Lei LC; Chen QX; Gao YW; Zhou HQ; Xiang H; Zheng HJ; Chern SW; Cheng F; Pan CM; Xuan H; Chen SJ; Luo HM; Zhou DH; Liu YF; He JF; Qin PZ; Li LH; Ren YQ; Liang WJ; Yu YD; Anderson L; Wang M; Xu RH; Wu XW; Zheng HY; Chen JD; Liang G; Gao Y; Liao M; Fang L; Jiang LY; Li H; Chen F; Di B; He LJ; Lin JY; Tong S; Kong X; Du L; Hao P; Tang H; Bernini A; Yu XJ; Spiga O; Guo ZM; Pan HY; He WZ; Manuguerra JC; Fontanet A; Danchin A; Niccolai N; Li YX; Wu CI; Zhao GP
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2430-5. PubMed ID: 15695582
[TBL] [Abstract][Full Text] [Related]
18. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.
Zhou Y; Lu K; Pfefferle S; Bertram S; Glowacka I; Drosten C; Pöhlmann S; Simmons G
J Virol; 2010 Sep; 84(17):8753-64. PubMed ID: 20573835
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
[TBL] [Abstract][Full Text] [Related]
20. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.
Liniger M; Zuniga A; Tamin A; Azzouz-Morin TN; Knuchel M; Marty RR; Wiegand M; Weibel S; Kelvin D; Rota PA; Naim HY
Vaccine; 2008 Apr; 26(17):2164-74. PubMed ID: 18346823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
